Fennec Pharmaceuticals (FENC) Total Debt Growth (1y) (2011 - 2017)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 5.94% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 103.99% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.07% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 505,960.61% |
| Sep 30, 2017 | 908.11% |
| Jun 30, 2017 | 239.29% |
| Mar 31, 2017 | 82.05% |
| Dec 31, 2016 | -59.76% |
| Sep 30, 2016 | -60.22% |
| Jun 30, 2016 | -81.88% |
| Mar 31, 2016 | -94.38% |
| Dec 31, 2015 | -93.78% |
| Sep 30, 2015 | -97.34% |
| Jun 30, 2015 | -94.21% |
| Mar 31, 2015 | -87.42% |
| Dec 31, 2014 | -53.93% |
| Sep 30, 2014 | -20.24% |
| Jun 30, 2014 | 99.25% |
| Mar 31, 2014 | -45.97% |
| Dec 31, 2013 | -56.88% |
| Sep 30, 2013 | 252.65% |
| Jun 30, 2013 | 142.13% |
| Mar 31, 2013 | 483.60% |
| Dec 31, 2012 | 30.79% |
| Sep 30, 2012 | -86.86% |
| Jun 30, 2012 | -84.73% |
| Dec 31, 2011 | -51.42% |